University of Leicester
Browse
1-s2.0-S0140673614622923-main.pdf (120.31 kB)

Care needed in interpretation of cancer survival measures.

Download (120.31 kB)
journal contribution
posted on 2017-01-23, 11:47 authored by Mark J. Rutherford
[First paragraph] Cancer patient survival obtained from population-based cancer studies is the optimum method to monitor and assess the effectiveness of patient care.1 Consideration of these estimates in conjunction with estimates of cancer incidence and mortality is still important.2 As a result, there is much interest in the assessment of progress in terms of cancer survival.3 and 4 Quantification of the improvements in cancer patient survival because of successes in some areas, such as treatment, diagnostic techniques, and awareness or screening campaigns, is of paramount importance to health-care officials, health policy makers, and charities supporting these developments in cancer control. However, to make a fair comparison—to compare like with like—is essential to assess progress accurately.

History

Citation

Lancet, 2015, 385 (9974), pp. 1162-1163

Author affiliation

/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Health Sciences

Version

  • VoR (Version of Record)

Published in

Lancet

Publisher

Elsevier

issn

0140-6736

eissn

1474-547X

Available date

2017-01-23

Publisher version

http://www.sciencedirect.com/science/article/pii/S0140673614622923

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC